HER2-negative breast cancer was identified by either the absence of HER2 protein staining (IHC 0); incomplete HER2 staining (IHC 1+); or moderate staining (IHC 2+) and negative testing for HER2 amplification by ISH. Here, ERBB2 is linked to breast cancer.